Teva launches perphenazine

Print Friendly, PDF & Email

NORTH WALES, Pa. — Teva Pharmaceuticals has introduced AB rated perphenazine tablets, USP.

Perphenazine Perphenazine, the generic version of Trilafon, is indicated for mental/mood disorders including schizophrenia, the manic phase of bipolar disorder, and schizoaffective disorder. The medicine helps reduce confusion and anxiety, treating nausea and vomiting and allowing patients to participate in everyday life. It can curtail aggressive behavior and the desire to harm oneself or others. It may also help to curb hallucinations.

Perphenazine is a medium-potency antipsychotic medication that aids in rebalancing natural substances, like dopamine, in the brain. Antipsychotics also limit the release of hormones from the hypothalamus and pituitary gland.

“Our customers count on Teva for a continuous supply of new generic products,” states Maureen Cavanaugh, the company’s chief operating officer for North America generics. “With the launch of perphenazine tablets, USP, we add another quality product to our broad line of affordable generic pharmaceuticals.”


TRP_728x90_9-21-21

PHILLYGLASS_728x90_7-29-21

Comments are closed.